These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11295841)

  • 41. Perspective on RET proto-oncogene and thyroid cancer.
    Le HN; Norton JA
    Cancer J; 2000; 6(2):50-7. PubMed ID: 11069217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical treatment of medullary carcinoma of the thyroid.
    Favia G; Lumachi F
    Tumori; 2001; 87(4):S49-51. PubMed ID: 11693822
    [No Abstract]   [Full Text] [Related]  

  • 43. Does a somatic deletion in RET clarify the sporadic nature of medullary thyroid carcinoma?
    Gimm O; Marsh DJ
    J Endocrinol Invest; 2003 Apr; 26(4):381-3. PubMed ID: 12841548
    [No Abstract]   [Full Text] [Related]  

  • 44. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.
    Feldman GL; Edmonds MW; Ainsworth PJ; Schuffenecker I; Lenoir GM; Saxe AW; Talpos GB; Roberson J; Petrucelli N; Jackson CE
    Surgery; 2000 Jul; 128(1):93-8. PubMed ID: 10876191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A primary, lateral-cervical medullary thyroid carcinoma: a case report.
    Santini L; Scurini C; Caracò C; Conzo G; Orabona P; De Rosa G; Fattoruso O; Colantuoni V
    J Clin Endocrinol Metab; 1996 May; 81(5):1784-6. PubMed ID: 8626835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RET activation in medullary carcinomas.
    Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
    Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
    [No Abstract]   [Full Text] [Related]  

  • 48. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ret proto-oncogene mutation found in the Czech population and its predictive value for offspring of patients with medullary carcinoma of the thyroid gland].
    Mazura I; Vcelák J; Bendlová B; Neradilová M; Nĕmec J; Stolba P
    Vnitr Lek; 1996 Nov; 42(11):751-6. PubMed ID: 9012117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [C cell hyperplasia and medullary microcarcinomas of the thyroid].
    Guyetant S; Saint-Andre JP
    Ann Pathol; 2000; 20 Suppl():S39-44. PubMed ID: 11261296
    [No Abstract]   [Full Text] [Related]  

  • 51. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
    Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
    Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The abnormal pentagastrin test.
    Gagel RF
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):221-2. PubMed ID: 8849578
    [No Abstract]   [Full Text] [Related]  

  • 53. Germline-sequence variants S836S and L769L in the RE arranged during Transfection (RET) proto-oncogene are not associated with predisposition to sporadic medullary carcinoma in the French population.
    Berard I; Kraimps JL; Savagner F; Murat A; Renaudin K; Nicolli-Sire P; Bertrand G; Moisan JP; Bezieau S
    Clin Genet; 2004 Feb; 65(2):150-2. PubMed ID: 14984475
    [No Abstract]   [Full Text] [Related]  

  • 54. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
    Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
    Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
    Hofstra RM; van der Luijt RB; Lips CJ
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2217-21. PubMed ID: 11757244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A RET double mutation in the germline of a kindred with FMTC.
    Bartsch DK; Hasse C; Schug C; Barth P; Rothmund M; Höppner W
    Exp Clin Endocrinol Diabetes; 2000; 108(2):128-32. PubMed ID: 10826520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions].
    Kalinin VN; Amosenko FA; Puskas C; Frilling A; Broelsch CE
    Genetika; 1998 Aug; 34(8):1157-9. PubMed ID: 9777362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.
    Hofstra RM; Fattoruso O; Quadro L; Wu Y; Libroia A; Verga U; Colantuoni V; Buys CH
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4176-8. PubMed ID: 9398735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
    Acton DS; Velthuyzen D; Lips CJ; Höppener JW
    Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.